Literature DB >> 7966508

The longitudinal stability of the Addiction Severity Index.

B E Stöffelmayr1, B E Mavis, R M Kasim.   

Abstract

The Addiction Severity Index (ASI) is a structured interview widely used by substance abuse clinicians and researchers for client screening, determining treatment needs, and assessing treatment outcomes. Previous researchers have evaluated inter-rater agreement, test-retest reliability, and concurrent validity. The present report describes the stability of ASI scores in longitudinal work. In the context of an ongoing treatment outcome evaluation study involving seven assessors, inter-rater agreement, inter-rater reliability, as well as intra- and inter-rater accuracy were assessed repeatedly during a 2-year period. The results show the scores derived from the ASI to be stable across assessors and over time. The relationship between stable scores and resources required for training are discussed.

Mesh:

Year:  1994        PMID: 7966508     DOI: 10.1016/0740-5472(94)90048-5

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  10 in total

1.  Cost-effectiveness of public sector substance abuse treatment: comparison of a managed care approach to a traditional public sector system.

Authors:  Martha C Beattie; Teh-Wei Hu; Rui Li; Jason C Bond
Journal:  J Behav Health Serv Res       Date:  2005 Oct-Dec       Impact factor: 1.505

2.  Prevalence and experience of chronic pain in suburban drug injectors.

Authors:  Robert Heimer; Weihai Zhan; Lauretta E Grau
Journal:  Drug Alcohol Depend       Date:  2015-03-19       Impact factor: 4.492

3.  Psychiatric Symptom Improvement in Women Following Group Substance Abuse Treatment: Results from the Women's Recovery Group Study.

Authors:  R Kathryn McHugh; Shelly F Greenfield
Journal:  J Cogn Psychother       Date:  2010-04-01

4.  Substance use and the quality of patient-provider communication in HIV clinics.

Authors:  P Todd Korthuis; Somnath Saha; Geetanjali Chander; Dennis McCarty; Richard D Moore; Jonathan A Cohn; Victoria L Sharp; Mary Catherine Beach
Journal:  AIDS Behav       Date:  2011-05

5.  How do residents of recovery houses experience confrontation between entry and 12-month follow-up?

Authors:  Douglas L Polcin; Gantt P Galloway; Jason Bond; Rachael Korcha; Thomas K Greenfield
Journal:  J Psychoactive Drugs       Date:  2010-03

6.  Associations between injection risk and community disadvantage among suburban injection drug users in southwestern Connecticut, USA.

Authors:  Robert Heimer; Russell Barbour; Wilson R Palacios; Lisa G Nichols; Lauretta E Grau
Journal:  AIDS Behav       Date:  2014-03

7.  Seroprevalence of HIV, hepatitis B virus, and HCV among injection drug users in Connecticut: understanding infection and coinfection risks in a nonurban population.

Authors:  Hana Akselrod; Lauretta E Grau; Russell Barbour; Robert Heimer
Journal:  Am J Public Health       Date:  2013-10-17       Impact factor: 9.308

8.  Prevention knowledge, risk behaviours and seroprevalence among nonurban injectors of southwest Connecticut.

Authors:  Lauretta E Grau; Weihai Zhan; Robert Heimer
Journal:  Drug Alcohol Rev       Date:  2016-04-13

9.  Safety of ibogaine administration in detoxification of opioid-dependent individuals: a descriptive open-label observational study.

Authors:  Thomas Knuijver; Arnt Schellekens; Maarten Belgers; Rogier Donders; Toon van Oosteren; Kees Kramers; Robbert Verkes
Journal:  Addiction       Date:  2021-08-09       Impact factor: 7.256

10.  Both localized and systemic bacterial infections are predicted by injection drug use: A prospective follow-up study in Swedish criminal justice clients.

Authors:  Disa Dahlman; Jonas Berge; Per Björkman; Anna C Nilsson; Anders Håkansson
Journal:  PLoS One       Date:  2018-05-31       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.